Home › Hemophilia B › Florida
Hemophilia B clinical trials in Florida
4 studies for Hemophilia B are looking for participants at sites in Florida.
Cities in Florida
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- USF Health Morsani Center For Advanced Healthcare, Tampa
- The University of South Florida Board of Trustees, Tampa
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT05568719Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
- University of Florida, Gainesville
RecruitingPhase 3
138 Months – 206 Months · Men · Updated Sep 16, 2026 · NCT07080905A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
- University of Florida, Gainesville
RecruitingPhase 1/2
Ages 2 and older · Men · Updated Sep 11, 2026 · NCT06379789ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- and 4 more
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.